Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Ruida Pharmaceutical Technology is a China-based enterprise specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. Located in the Zhengzhou High-tech Industrial Development Zone, the company focuses on providing high-quality chemical building blocks for the synthesis of active pharmaceutical ingredients (APIs), particularly in the antiviral and cardiovascular therapeutic areas. Their product portfolio includes key intermediates for major drugs such as Tenofovir, Entecavir, and Ticagrelor. Henan Ruida offers custom synthesis and contract manufacturing services (CMO) to global pharmaceutical and biotechnology companies, leveraging advanced organic synthesis capabilities and rigorous quality control systems. The company is a significant contributor to the pharmaceutical supply chain in the Henan province, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Ruida Pharmaceutical Technology.